PDS Biotechnology (FRA:EU6) Tariff Resilience Score: 7/10 (As of Jul. 09, 2026)


FRA:EU6 PDS Biotechnology Corp FRA:EU6
31 GF Score
Price €0.73
! 1 Warning Sign
View Full Analysis

What is PDS Biotechnology Tariff Resilience Score?

PDS Biotechnology FRA:EU6 -1.89% 31 Tariff Resilience Score is 7 as of Jul. 09, 2026. GuruFocus rates FRA:EU6 with a GF Score™ of 31/100. The stock has 1 warning sign investors should review. Among 1,368 Biotechnology companies, PDS Biotechnology ranks better than 90.35% on this metric.

PDS Biotechnology has the Tariff Resilience Score of 7, which implies that the company might have Highly Resilient.

PDS Biotechnology has PDS Biotechnology's focus on biotech R&D and domestic partnerships limits its direct exposure to tariffs. While global supply chains for materials exist, the impact is mitigated by the company's innovation-driven model.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes PDS Biotechnology might have Highly Resilient.

PDS Biotechnology  (FRA:EU6) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

PDS Biotechnology Tariff Resilience Score Related Terms

FRA:EU6 vs LTRN, AURX, VERU: Tariff Resilience Score Comparison

For the Biotechnology subindustry, PDS Biotechnology's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PDS Biotechnology Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PDS Biotechnology's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where PDS Biotechnology's Tariff Resilience Score falls into.


FRA:EU6
31GF Score
PDS Biotechnology Corp FRA:EU6
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 7 mean?
PDS Biotechnology (FRA:EU6) has a Tariff Resilience Score of 7 as of Jul. 09, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, PDS Biotechnology ranks #132 out of 1368 companies in the Biotechnology industry, placing it in the top 9.6%.
Is PDS Biotechnology's Tariff Resilience Score too high?
PDS Biotechnology's current Tariff Resilience Score is 7. The Biotechnology industry median Tariff Resilience Score is 4.00. PDS Biotechnology's value of 7 is 75% above this industry median. Based on the distribution chart, PDS Biotechnology ranks #132 out of 1368 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, PDS Biotechnology has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does PDS Biotechnology's Tariff Resilience Score compare to LTRN and AURX?
According to the Biotechnology industry distribution chart, PDS Biotechnology ranks #132 out of 1368 companies for Tariff Resilience Score. This places PDS Biotechnology in the top 10% of its industry — outperforming the majority of peers. The industry median Tariff Resilience Score is 4.00. PDS Biotechnology's value of 7 is 75% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,368 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PDS Biotechnology's current Tariff Resilience Score of 7 is 75% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PDS Biotechnology's current Tariff Resilience Score is 7. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PDS Biotechnology stock overvalued right now?
PDS Biotechnology (FRA:EU6) has a current Tariff Resilience Score of 7. The current Tariff Resilience Score is 7 and 75% above the Biotechnology industry median of 4.00. PDS Biotechnology's overall GF Score™ is 31/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For PDS Biotechnology (FRA:EU6), the current Tariff Resilience Score is 7 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PDS Biotechnology Business Description

Other Exchanges PDSB:USA
Address 303A College Road, East Princeton, NJ, USA, 08540
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy.
31GF Score

Get the complete analysis for FRA:EU6

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.73
Price